rs144057685
Positions:
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_ModerateBS1_SupportingBS2
The ENST00000682892.1(EIF2AK3):c.-145-13622A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00798 in 586,120 control chromosomes in the GnomAD database, including 30 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.0066 ( 4 hom., cov: 32)
Exomes 𝑓: 0.0085 ( 26 hom. )
Consequence
EIF2AK3
ENST00000682892.1 intron
ENST00000682892.1 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.256
Genes affected
EIF2AK3 (HGNC:3255): (eukaryotic translation initiation factor 2 alpha kinase 3) The protein encoded by this gene phosphorylates the alpha subunit of eukaryotic translation-initiation factor 2, leading to its inactivation, and thus to a rapid reduction of translational initiation and repression of global protein synthesis. This protein is thought to modulate mitochondrial function. It is a type I membrane protein located in the endoplasmic reticulum (ER), where it is induced by ER stress caused by malfolded proteins. Mutations in this gene are associated with Wolcott-Rallison syndrome. [provided by RefSeq, Sep 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -7 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.3).
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0066 (1005/152318) while in subpopulation NFE AF= 0.0105 (714/68010). AF 95% confidence interval is 0.00986. There are 4 homozygotes in gnomad4. There are 444 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAd4 at 4 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EIF2AK3 | XM_047446428.1 | c.17+214A>G | intron_variant | XP_047302384.1 | ||||
EIF2AK3 | NM_004836.7 | upstream_gene_variant | ENST00000303236.9 | NP_004827.4 | ||||
EIF2AK3 | XM_047446430.1 | upstream_gene_variant | XP_047302386.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EIF2AK3 | ENST00000682892.1 | c.-145-13622A>G | intron_variant | ENSP00000507214 | ||||||
EIF2AK3 | ENST00000303236.9 | upstream_gene_variant | 1 | NM_004836.7 | ENSP00000307235 | P1 | ||||
EIF2AK3 | ENST00000652423.1 | upstream_gene_variant | ENSP00000498948 |
Frequencies
GnomAD3 genomes AF: 0.00661 AC: 1006AN: 152200Hom.: 4 Cov.: 32
GnomAD3 genomes
AF:
AC:
1006
AN:
152200
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00846 AC: 3672AN: 433802Hom.: 26 Cov.: 6 AF XY: 0.00863 AC XY: 1879AN XY: 217852
GnomAD4 exome
AF:
AC:
3672
AN:
433802
Hom.:
Cov.:
6
AF XY:
AC XY:
1879
AN XY:
217852
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00660 AC: 1005AN: 152318Hom.: 4 Cov.: 32 AF XY: 0.00596 AC XY: 444AN XY: 74488
GnomAD4 genome
AF:
AC:
1005
AN:
152318
Hom.:
Cov.:
32
AF XY:
AC XY:
444
AN XY:
74488
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3
AN:
3478
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Uncertain:1Benign:1
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jun 01, 2023 | EIF2AK3: BS1, BS2 - |
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Jun 15, 2017 | - - |
Wolcott-Rallison dysplasia Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at